Eylea and Eylea HD (aflibercept) are prescription drugs used to treat certain types of eye conditions. Each comes as a liquid solution given as an injection into the eye. The dosing schedules can vary ...

Please provide your email address to receive an email when new articles are posted on . Eylea HD was approved for patients with wet age-related macular degeneration, diabetic macular edema and ...

Eylea is a brand-name biologic prescription medication containing the active ingredient aflibercept. Generic versions of biologic drugs are called biosimilars. Due to the complex manufacturing process ...

Aflibercept 8mg (0.07mL of 114.3mg/mL); per vial; soln for oph intravitreal inj; preservative-free. A single-dose glass vial containing one Eylea HD 8 mg (0.07 mL of a 114.3 mg/mL solution); or A vial ...

The FDA granted approval to Biocon Biologics’ drug Yesafili and Samsung Bioepis and Biogen’s drug Opuviz, the agency announced May 20. The two drugs are biosimilars for Eylea, an injection made by ...

Three months after a federal judge in West Virginia sided with Regeneron, blocking the market entry of two biosimilars for blockbuster eye disease drug Eylea, the same judge has rejected the company’s ...

Please provide your email address to receive an email when new articles are posted on . The FDA did not approve the supplemental biologics license application for Eylea HD. The application would have ...